Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Medtronic PLC    MDT   IE00BTN1Y115

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Medtronic : NPPA SENDS MIXED SIGNALS WITH NOD FOR ABBOTT STENT WITHDRAWAL

share with twitter share with LinkedIn share with facebook
share via e-mail
0
09/28/2017 | 02:00am CEST

The National Pharmaceutical Pricing Authority (NPPA) has allowed Abbott Healthcare to discontinue its drug-eluting stent, Alpine, from the Indian market - a decision that is sending mixed signals to the market. The NPPA has already permitted Abbott to withdraw its dissolvable stent, Absorb, from the market. NPPA's move has raised concerns over a 'sudden shortage' of cardiac stents in the market. NPPA has brought cardiac stents under price control and reduced the price of a drug-coated stent to Rs30,000 from Rs1.5- 1.9 lakh earlier. However, companies like Abbott and Medtronic have decided to withdraw some of their top drug-eluting stents from the Indian market as their margins would get hit.

Copyright (c) 2017 . Informatics India Ltd., source Indian Business Insight

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on MEDTRONIC PLC
10:07a MEDTRONIC : Care Management Services and American Well Announce Strategic Partne..
10/17 MEDTRONIC : Care Management Services, American Well Announce Strategic Partnersh..
10/17 MEDTRONIC : Care Management Services and American Well Announce Strategic Partne..
10/17 MEDTRONIC : and Mercy Announce Data Sharing Partnership to Accelerate Medical De..
10/16 MEDTRONIC : Care Management Services and American Well Announce Strategic Partne..
10/13 MEDTRONIC : Prosthetics-Seattle (Medtronic) Pay Only DOS 09/18/17 (VA-18-919420)..
10/13 MEDTRONIC : 65-- Prosthetics-Seattle (Medtronic) Pay Only DOS 09/18/17 (VA-18-91..
10/13 65-- RFI MEDTRONIC - NX EQ RADIO FRE : Tissue Ablation Program;
10/13 MEDTRONIC : and Mercy Announce Data Sharing Partnership to Accelerate Medical De..
10/12 MEDTRONIC : Animas Corporation to Close Operations and Exit Insulin Pump Market
More news
News from SeekingAlpha
10/17 YOUR DAILY PHARMA SCOOP : Everybody's Gilead Problem, Halozyme's Further Progres..
10/12 Wright Can't Get It Right
10/12 My Dividend Growth Portfolio - Q3 2017 Summary
10/12 The Lower Volatility Stock Portfolio For Retirees And Others
10/10 YOUR DAILY PHARMA SCOOP : MannKind Is A Trade Not An Investment; AstraZeneca's I..
Financials ($)
Sales 2018 29 262 M
EBIT 2018 8 209 M
Net income 2018 4 607 M
Debt 2018 16 892 M
Yield 2018 2,36%
P/E ratio 2018 23,78
P/E ratio 2019 20,21
EV / Sales 2018 4,19x
EV / Sales 2019 3,95x
Capitalization 106 B
Chart MEDTRONIC PLC
Duration : Period :
Medtronic PLC Technical Analysis Chart | MDT | IE00BTN1Y115 | 4-Traders
Technical analysis trends MEDTRONIC PLC
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Average target price 90,0 $
Spread / Average Target 15%
EPS Revisions
Managers
NameTitle
Omar S. Ishrak Chairman & Chief Executive Officer
Mark Ploof Senior Vice President-Global Operations
Karen L. Parkhill Chief Financial Officer & Executive Vice President
Richard E. Kuntz Chief Scientific, Clinical & Regulatory Officer
Richard H. Anderson Lead Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
MEDTRONIC PLC9.60%105 658
BAXTER INTERNATIONAL41.68%34 828
ZIMMER BIOMET HOLDINGS INC15.99%24 249
C R BARD INC43.94%23 585
HOYA CORPORATION28.43%21 932
TERUMO CORP7.75%15 755